Question 1

What is Abbott Laboratories's WACC?

Accepted Answer

Abbott Laboratories (ABT) has a Weighted Average Cost of Capital (WACC) of 6.40%. This is calculated using a Cost of Equity of 7.47% (via CAPM with a beta of 0.53) and a pre-tax Cost of Debt of 2.00%, with an equity weight of 81.72% in the capital structure.

Question 2

Is Abbott Laboratories's WACC high or low?

Accepted Answer

Abbott Laboratories's WACC of 6.40% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Abbott Laboratories's WACC calculated?

Accepted Answer

Abbott Laboratories's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 7.47% is derived from the CAPM model using a beta of 0.53. The pre-tax Cost of Debt (Rd) is 2.00%. The capital structure is 81.72% equity and 18.28% debt.

Abbott Laboratories (ABT) — WACC 分析

WACC 构成

解读

Abbott Laboratories（ABT）WACC：6.40%

WACC计算器

Abbott Laboratories（ABT） WACC 解读

ABT 公司分析

ABT DCF 估值

继续做同行对比